Aetina Showcases Full-Stack Edge AI Innovations at COMPUTEX 2025, Driving Generative AI and Intelligent Applications at the Edge
TAIPEI, May 12, 2025 /PRNewswire/ -- Aetina, a leading provider of edge AI solutions, is set to showcase its comprehensive edge AI computing portfolio at COMPUTEX 2025 (May 20th –23rd, Taipei Nangang Exhibition Center, Hall 1, Booth J0118). The...
Xailient and Konami to Debut Privacy-Safe Biometric Innovation for Table Games at G2E Asia 2025
MACAU, May 9, 2025 /PRNewswire/ -- Xailient Inc., the world leader in privacy-safe computer vision AI, today announced the debut of a groundbreaking biometric innovation in partnership with global gaming leader Konami Gaming, Inc. At G2E Asia 2025,...
Autoliv Announces Results of 2025 Annual Stockholders Meeting
DETROIT, May 9, 2025 /PRNewswire/ -- Autoliv, Inc., (NYSE: ALV) (SSE: ALIV.sdb), the worldwide leader in automotive safety systems, today announced the results of its annual general meeting of stockholders held on May 8, 2025. Annual General Meeting...
Hanx Biopharmaceuticals, Ltd. Showcases Five Innovative Cancer Therapies at 2025 AACR Annual Meeting
CHICAGO, May 7, 2025 /PRNewswire/ -- Hanx Biopharmaceuticals Ltd. (HanxBio), a clinical-stage biotechnology company pioneering next-generation immunotherapies, highlighted its expanding oncology and autoimmune disease pipeline with five research...
Successful Extension of Nucleic Acid Aptamer Pharmacokinetics in Joint Research by Ajinomoto Co., Inc. and RIBOMIC Inc.
AJICAP® Antibody-Drug Conjugate Manufacturing Technology Contributes to Enhanced Efficacy of Antibody Drugs TOKYO, May 7, 2025 /PRNewswire/ -- Ajinomoto Co., Inc. (President: Shigeo Nakamura, Headquarters: Chuo-ku, Tokyo, hereinafter referred to as...
Bispecific vs. Bispecific: Innovent Announces First Patient Dosed in the Phase 2 Clinical Study of Efdamrofusp Alfa (IBI302), a First-in-class Anti-VEGF and Anti-Complement Bispecific Fusion Protein for the Treatment of Diabetic Macular Edema
SAN FRANCISCO and SUZHOU, China, May 7, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of...
Paradigm Therapeutics, Inc. Announces Investment by Eshelman Ventures, LLC to Support Completion of Development of SD-101 (Zorblisa™), A Topical Therapy for Treatment Across the Entire Skin Surface of All Subtypes of Epidermolysis Bullosa (EB)
First Topical Therapy Developed to Treat the Wounds and Lesions on the Entire Skin Surface Across All EB Subtypes Funding to be Used for Completion of All Activities to Support Planned NDA Submission in the Second Half of 2025, Along with Plans for...
TTEC Expands India Operations with New Mohali Customer Experience Center, Adding 400 New Jobs
AUSTIN, Texas and MOHALI, India, May 6, 2025 /PRNewswire/ -- TTEC Holdings, Inc. (NASDAQ: TTEC), a leading global customer experience (CX) technology and services innovator, today announced the expansion of its India operations with a new customer...
Sycomp Expands Locations and Warehouse Capacity to Support Global Customers
FOSTER CITY, Calif., May 6, 2025 /PRNewswire/ -- Sycomp A Technology Company, Inc., announced today the expansion of its global operations with new locations in Germany, Iceland, Nigeria, Saudi Arabia, Spain, Sri Lanka and Uruguay. Concurrently, the...
China Automotive Systems to Announce Unaudited 2025 First Quarter Financial Results on May 14, 2025
WUHAN, China, May 6, 2025 /PRNewswire/ -- China Automotive Systems, Inc. (Nasdaq: CAAS) ("CAAS" or the "Company"), a leading power steering components and systems supplier in China, today announced that it will issue unaudited financial results for...